Genelux (GNLX) Research & Development (2022 - 2026)

Genelux's Research & Development history runs 5 years deep, the most recent figure standing at $5.8 million for Q1 2026.

• On a quarterly basis, Research & Development rose 22.99% year-over-year to $5.8 million in Q1 2026; TTM through Mar 2026 was $20.9 million, a 6.32% increase from a year earlier, with the FY2025 full-year figure at $19.9 million, up 4.49% from the prior year.
• Research & Development grew to $5.8 million in Q1 2026 per GNLX's latest filing, from $5.7 million in the prior quarter.
• Across five years, Research & Development topped out at $6.5 million in Q4 2024 and bottomed at $2.4 million in Q3 2022.
• The 5-year median for Research & Development is $4.2 million (2023), against an average of $4.2 million.
• Across the five-year window, Research & Development jumped 68.56% in 2023 and slipped 13.28% in 2025, its largest moves.
• Year by year, Research & Development stood at $2.5 million in 2022, then soared by 68.56% to $4.2 million in 2023, then soared by 56.73% to $6.5 million in 2024, then declined by 13.28% to $5.7 million in 2025, then gained by 2.19% to $5.8 million in 2026.
• Per Business Quant, the three latest GNLX Research & Development figures stand at $5.8 million (Q1 2026), $5.7 million (Q4 2025), and $4.7 million (Q3 2025).